(1)
Prevalence of Persistent Hypogammaglobulinemia in Patients With Autoimmune Disease Receiving Rituximab at a National Referral Center in Mexico. Rev Alerg Mex 2023, 69 (4), 171-182. https://doi.org/10.29262/ram.v69i4.1142.